Stanford researchers first used gene expression profiling to distinguish cancer sub-types
In 2000, Stanford researchers led by Ash Alizadeh announced they had used gene expression profiling to identify two…
Georgetown University Hospital became part of MedStar Health
In 2000, the Georgetown University Hospital became part of MedStar Health, a not-for-profit network of seven hospitals in…
Georgetown Lombardi Comprehensive Cancer Center was founded
In 2000, Georgetown Lombardi Comprehensive Cancer Center, was founded when the Georgetown University Medical Center authorized the establishment…
Eli Lilly and Takeda Chemical Industries launched Actos, an oral antidiabetes agent
In 2000, Eli Lilly and Takeda Chemical launched Actos, an oral anti diabetes agent. In 2005, a PROactive…
Fox Chase Cancer Center received Magnet Designation for Nursing Excellence
In 2000, Fox Chase Cancer Center received Magnet Designation for Nursing Excellence from the American Nurses Credentialing Center….
Biotechnology | FDA | Oncology | Therapeutics
FDA approved Targretin to treat certain T-cell lymphomas
On Dec. 29, 1999, the U.S. Food and Drug Administration (FDA) approved Bexarotene (Targretin) to treat cutaneous T-cell…
The National Cancer Institute published Atlas of Cancer Mortality, 1950-94, showing geographic patterns of cancer death rates across U.S.
On Dec. 8, 1999, the National Cancer Institute published the Atlas of Cancer Mortality, 1950-94, showing the geographic…
Alvin and Ruth Siteman donated $35 to establish the Siteman Cancer Center
On Dec. 2, 1999, Alvin and Ruth Siteman donated $35 million to establish the Alvin J. Siteman Cancer…
The National Cancer Institute awarded nearly $8 million in grants toward Early Detection Research Network
On Nov. 23, 199, the National Cancer Institute awarded nearly $8 million in grants toward the creation of…
NeoPath merged with AutoCyte to create TriPath Imaging
On Jun. 7, 1999, NeoPath merged with AutoCyte to form TriPath Imaging based in Burlington, N.C. NeoPath was…
The Hybrid Capture II human papillomavirus (HPV) DNA test was approved by the FDA
On Mar. 17, 1999, the Hybrid Capture II human papillomavirus (HPV) DNA test was approved by the U.S….
The Indiana University Cancer Center became an NCI-designated cancer center
In 1999, The Indiana University (IU) Cancer Center became an National Cancer Institute (NCI)-designated cancer center. Its mission…
The Hudson-Webber Cancer Research Center opened
In 1999, the Hudson-Webber Cancer Research Center opened to serve as a ‘translational’ research facility, bridging the gaps…
Timothy J Eberlein, MD was named director of the Alvin J Siteman Cancer Center
In 1999, Timothy J. Eberlein, MD was named director of the Alvin J. Siteman Cancer Center. As director…
Washington University – St Louis radiation oncologists helped develop the world’s first big bore CT scanner
In 1999, Washington University – St. Louis radiation oncologists were instrumental in developing the world’s first big bore…
Biotechnology | NIH | Oncology | Therapeutics
The Eppley Cancer Center became a National Cancer Institute designated cancer center
In 1999, the Eppley Cancer Center became a National Cancer Institute (NCI) designated cancer center. NCI grant funding…
American Association for Cancer Research Scientist-Survivor Program was founded
In 1999, American Association for Cancer Research (AACR) Scientist-Survivor Program which united researchers with patients and survivor advocates…
The Prostate Centre at VGH received $20 million donation by Vancouver businessman Jim Pattison
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
Michael Smith Genome Science Centre was founded
In 1999, Michael Smith, recipient of the 1993 Nobel Prize in Chemistry, founded Canada’s Michael Smith Genome Science…
Trubion Pharmaceutical was founded
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
Mouse model of prostate cancer was developed at Washington University – St Louis
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
Medical College of Georgia researchers identified enzyme role in preventing a mother’s immune system from rejecting a fetus
On Sept. 8, 1998, the Medical College of Georgia researchers Dr. David Munn and immunologist Andrew Melllor identified…
The Seattle Cancer Care Alliance was formed
On Jun. 16, 1998, University of Washington Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s announced the…
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Genentech drug Xeloda (capecitabine)
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…
Seattle Genetics was incorporated
On Jan. 13, 1998, Seattle Genetics (Seagen) was founded in Bothell as a biotechnology company focused on developing…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The City of Hope Cancer Center received NCI comprehensive cancer center designation
In 1998, National Cancer Institute (NCI) awarded the City of Hope Cancer Center NCI-comprehensive cancer center designation. City…
The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
Dr. Patrick Lee developed a reovirus that can infect and kill cancer cells without harming healthy cells
In 1998, University of Calgary’s Dr. Patrick Lee revealed that reovirus injected in mice shrank tumours from brain…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
Cancer incidence rates showed first sustained decline since NCI began keeping records in 1973
In 1998, Cancer incidence rates showed first sustained decline since the National Cancer Institute (NCI) began keeping records…
Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some cancers
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…